1. General Information 
2. Copyright, Licensing, Publication Rights 
3. Originality and plagiarism 
4. Types of Articles 
5. Manuscript Preparation
6. Proofs
7. Terms of Submission
8. Registration
9. Reporting Clinical Trials
10. Changes to authorship 
11. Peer Review
12. Article Processing Charges (APC)

1- General Information: 

• Egyptian Journal of Medical Microbiology is the official journal of Egyptian Society for Medical Microbiology and is a peer-reviewed journal is interested in new researches in the different branches of Microbiology and immunology. The journal covers the following areas: Pathogenicity and virulence; Host response; Diagnostics, Genetics, Antimicrobial agents and chemotherapy; Epidemiology; Prevention of hospital infections and Infection Control, Clinical and applied Microbiology, Virology and Mycology, Veterinary Microbiology and Oral Microbiology.
• Egyptian Journal of Medical Microbiology follows the ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.  https://www.icmje.org/recommendations/browse/about-the-recommendations/purpose-of-the-recommendations.html  
• Egyptian Journal of Medical Microbiology follows all guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from ICMJEE (https://www.icmje.org/icmje-recommendations.pdf) and Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice). 
• The journal will not consider any manuscript previously published nor under review by any other journals. Once accepted for review, the manuscript must not be submitted elsewhere. Unethical publishing, such as plagiarism, undisclosed conflicts of interest, inappropriate authorship, and duplicate publication are forbidden. 
• Ethical responsibilities of authors: Authors must disclose any financial relationship(s) at submission, and the authors must update any disclosures prior to publication. The authors must also state any Information that could be perceived as potential conflict(s) of interest that includes, but is not limited to, grants or funding, employment, affiliations, royalties, patents, honoraria, consultancies, inventions, stock options/ownership, or expert testimony.
• Manuscripts must be written in English and to be 'spell-checked' and 'grammar checked'. 
• Online submission: All manuscripts should be sent on line Via Egyptian Journal of Medical Microbiology website (https://ejmm.journals.ekb.eg/contacts?_action=loginForm). Manuscript should be prepared according to Manuscript preparation (see the relevant section below). 

2- Copyright, Licensing, Publication Rights:

• Egyptian Journal of Medical Microbiology is published under the Creative Commons CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/), which allows unrestricted reuse of the material with proper attribution. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of these articles.
• Authors have copyright but license exclusive rights in their article to the publisher (Egyptian Society for Medical Microbiology) ^*.
• Authors have the right to:                                                                                   

            . Share their article according to the [Personal Use rights]^** so long as it contains the end-user license and the DOI link to the version of record in this journal.

            . Retain intellectual property rights (including research data).

            . Proper attribution and credit for the published work.

• ^* This includes the right to make and authorize commercial use.
• ^** Personal use rights:

Authors can use their articles, in full or in part, for scholarly, non-commercial purposes such as:

• Use by an author in the author’s teaching activities (including distribution of copies, paper, or electronic).
• Distribution of copies to known research colleagues for their personal use (but not for Commercial Use).
• Inclusion in a thesis or dissertation (if this is not to be published commercially).
• Use in a subsequent compilation of the author’s works.
• Extending the Article to book-length form.
• Preparation of other derivative works (but not for Commercial Use). 

3- Originality and plagiarism: 

• The authors should ensure that they have written entirely original works. If the authors have used the work and/or words of others that this has been appropriately cited or quoted.
• To verify originality, your article may be checked by the originality detection service. All new submissions are automatically screened for plagiarism within the editorial system. Editors may also choose to run a similarity report at any other stage during the peer review process or post-publication.

4- Types of Articles: 

The journal editorial board is considering for publication the following: 

a)- Research Articles 

- Should report relevant original research not published before, in the following format: 

• Word limit: 3500 words (excluding the abstract and references). 
• Abstract: structured up to 300 words to include Background, Methods, Results, and Conclusions. 
• References: 40 or less. 
• Tables and figures: no more than 7 Tables/Figures. 

b)- Short Reports (case reports)

- Should describe a case or several cases presenting with an unusual clinical aspect of a disease or novel perspectives upon, or solutions to, clinically relevant issues in the following format: 

• Word limit: 1000 words (excluding the abstract and references). 
• Abstract: unstructured of no more than 200 words. 
• References: 10-12 
• Tables and figures: no more than 2 Tables/Figures 

c)-  Review Articles 

- Review topics should be related to all fields of clinical and basic medical sciences and should reflect trends and progress or synthesis of data in the following format: 

• Word limit: 4000 words (excluding the abstract and references). 
• References: 40 or less. 
• Abstract: Up to 150 words, unstructured. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures. 

d)- Systematic review or meta-analysis 

- Topics should be related to all fields of clinical and basic medical sciences and should reflect trends and progress or synthesis of data in the following format: 

• Word limit: 4000 words (excluding the abstract and references). 
• References: 50 or less. 
• Abstract: Up to 350 words, unstructured. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures. 

e)-  Mini-review article 

- Review topics should be related to clinical aspects of infectious diseases, public health and infection control and should reflect trends and progress or synthesis of data in the following format: 

• Word limit: 2000 words (excluding the abstract and references).
• References: 20 or less. 
• Abstract: Up to 150 words, unstructured. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures. 

f)-  Editorials 

- Editorials are solicited by the editorial board members or those who are invited by Editor-in-Chief in the following format: 

• Word limit: 1200 words. 
• Tables/Figures: A maximum of 1 figure or table. 
• References: 10 or less. 
• Ensure that there is a clear message in the conclusion. 

g)-  Letter to the Editor 

These should be submitted in response to recently published articles in the journal addressing a specific issue and to introduce a focused scientific opinion or point of view, in the following format: 

• Word limit: 500 words. 
• Abstract: none. 
• Tables/Figures: A maximum of 1 figure or table. 
• References: 10 or less. 
• No subheadings. 
• Begin with ‘Dear Editor 

h)-  Continuous Medical Education Forum (For EB)

-  This type of article is restricted to The Journal Editorial Board (EB). The CME Forum from EB will be presented as a case presentation or clinical vignette scenario quiz.  

5- Manuscript Preparation:

-  The manuscript submitted to Egyptian Journal of Medical Microbiology should be word-processed and typed on one column. With the same rules, abstracts are typed on one column followed by keywords. Pages should have a margin of 2.5 cm. The text is double-spaced; uses a 12-point font in Times New Roman. 

-  The submitted manuscript should include: 

5.1. Cover Page

5.2. Title Page

5.3. Abstract

5.4. Introduction

5.5. Methodology

5.6. Results

5.7. Discussion

5.8. Conclusions

5.9. Conflict of Interest

5.10. References

5.11. Tables

5.12. Figures

5.13. Supplemental Material 

5.1. Cover page 

- The manuscript should be submitted with a cover letter stating the following: 

• That the manuscript is submitted for consideration for publication in Egyptian Journal of Medical Microbiology. Please specify the category of the submitted manuscript. 
• That the research contained in the manuscript has not been published, and the manuscript is not under consideration elsewhere. 
• Authors contribution: 

- Each author is required to declare his or her individual contribution to the article

• All authors must have materially participated in the research and/or article preparation, so roles for all authors should be described.
• The statement that all authors have approved the final article should be true and included in the disclosure.

5.2. Title page 

-     This page should include: 

• The article type: Original article, short report, review article, etc. 
• Title of paper: concise and informative. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication.  This responsibility includes answering any future queries about   Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author. 
• Conflict of Interest: Any financial or personal relationships with other people or organizations that could inappropriately influence (bias) the authors' actions. 
• Financial Disclosures: Any specific financial interests, relationships and affiliations relevant to the subject of the manuscript. These can include employment, consultancies, honoraria, stock ownership, etc. 

5.3. Abstract 

•  The abstract should be self-contained, citation-free and should not exceed the word limits of the article type.
•  Keywords: Up to five keywords should be provided at the end of the Abstract using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'), separated by semicolons. 

5.4. Introduction

• This section should be succinct, with no subheadings. The Introduction should contain a clear statement of the objectives of the work

5.5. Methodology

• Sufficient information should be given to permit repetition of the experimental work. 
• Informed consent and ethics committee/IRB approval: A paper describing experimental work in humans must: (1) indicate that informed consent has been obtained from patients where appropriate, (2) include a statement that the responsible ethics committee with date and number of ethical approval.
• Studies in humans and animals: If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association(Declaration of Helsinki) for experiments involving humans (see: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research- involving-human-subjects/). The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. 
• Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
• All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for  animal experiments,  or the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The authors will be held responsible for false statements or for failure to fulfill the above-mentioned requirements. 
• Equipment: Manufacturer, city, state and country must be given. 
• Chemical substances: must be properly identified. Except for standard laboratory chemicals, the source of supply must be given. Drugs must be identified by the generic or official name wherever possible. Proprietary names should be avoided. 
• Genes: Italic characters should be used for gene symbols including genotypes, alleles etc. 
• Units of measurement: Units should conform to the SI convention, except for blood pressure (which should be expressed in mmHg) and hemoglobin (g/l). Gas or pressure values should be given as mmHg with kPa in parentheses or vice versa. Where molecular weight is known, the amount of a substance should be expressed in mol or appropriate subunit (mmol etc.). Energy should be expressed in kJ. 
• Statistical analyses: Describe statistical methods in sufficient detail to enable a knowledgeable reader with access to the original data to verify the reported results.  Computer software packages that are used for anything other than widely known standard statistical procedures should be identified by name or acronym and by author or organization of origin. When variability is expressed in terms of the SEM or SD, the number of observations (n) must also be given. Both the sample size and statistical significance with p values should be predefined.

5.6. Results 

• The results should be stated concisely without discussion and should not normally contain any references. The same data should not be presented in figures and tables. Do not repeat all the data that are set out in the tables or figures in the text; emphasize or summarize only important observations. 

5.7. Discussion

• The Discussion should deal with the interpretation of the results and not recapitulate them. We encourage authors to    write their Discussion in a structured way.

5.8. Conclusions

• The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.  

5.9. Conflict of Interest

• All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work.
• Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/ registrations, and grants or other funding

5.10. References

• Authors are responsible for ensuring that the information in each reference is complete and accurate.
• All references must be numbered consecutively and citations of references in text should be identified using numbers in superscript form (e.g., “as discussed by Smith ⁹; “as discussed elsewhere ^{9, 10}”).
• All references should be cited within the text; otherwise, these references will be automatically removed.

Examples of reference style:

- Reference to a journal publication:

1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2010;163:51–9.

- Reference to a book:

2. Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.

-  Reference to a chapter in an edited book:

3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304. 

- Reference to a website:

4. Cancer Research UK. Cancer statistics reports for the UK, http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/; 2003 [accessed 13.03.03].

5.11. Tables

• Tables should be cited consecutively in the text.
• Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used. 

5.12. Figures

• Each figure should be supplied in a separate electronic file.
• All figures should be cited in the paper in a consecutive order.
• Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel, etc.) or bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.).
• Bitmap images should be of 300 dpi resolution at least unless the resolution is intentionally set to a lower level for scientific reasons. If a bitmap image has labels, the image and labels should be embedded in separate layers.

5.13. Supplemental Material 

• These should be submitted with the manuscript for peer-review and approval by the Editors. Supplemental material, which should be referenced in the body of the main text, can include figures, tables, movies, and animations (extra- material beyond the journal limit of tables/figures for each manuscript format). Supplemental Material will be published Online-only as submitted. It will not be copyedited or formatted by the publisher in any way. The accuracy and presentation of Supplemental Material is the sole responsibility of the authors. Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. 

Acknowledgments

All acknowledgments (if any) should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth.

6- Proofs

• Corrected proofs must be returned to the publisher within 2-3 days of receipt.
• The publisher will do their effort to ensure prompt publication. It will therefore be appreciated if the manuscripts and figures conform from the outset to the style of the journal.

7- Terms of Submission

• Manuscripts should be submitted by one of the authors of the manuscript through the online Manuscript Tracking System (MTS).
• Submissions by anyone other than one of the authors will not be accepted. The submitting author takes responsibility for the paper during submission and peer review.
• Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
• The submitting author is responsible for ensuring that the article's publication has been approved by all the other coauthors.
• It is also the authors' responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution.
• Only an acknowledgment from the editorial office officially establishes the date of receipt.
• Further correspondence and proofs will be sent to the corresponding author before publication who will be responsible to get the approval of all coauthors on the final proof. It is a condition of submission of a paper that the authors permit editing of the paper for readability.

8- Registration

• Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors
• Trials must register at or before the onset of patient enrolment.
• The clinical trial registration number should be included at the end of the abstract of the article.

9- Reporting Clinical Trials 

• Randomized controlled trials should be presented according to the CONSORT guidelines.
• At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure.

10- Changes to authorship 

• Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission.
• Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor.
• To request such a change, the Editor must receive the following from the corresponding author:

• The reason for the change in author list
• Written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement.
• In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
• Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted.
• While the Editor considers the request, publication of the manuscript will be suspended
• All enquiries concerning the publication of accepted papers should be addressed to https://ejmm.journals.ekb.eg/

11- Peer Review

• All manuscripts are subject to peer review and are expected to meet standards of academic excellence.
• Submissions will be considered by an editor and—if not rejected right away—by peer-reviewers, whose identities will remain anonymous to the authors.

12- Article Processing Charges (APC)

• EJMM is an open-access journal. Open access charges allow publishers to make the published material available for free to all interested online visitors. The standard APC for authors is US$100, including 20% VAT tax. Authors from Low or Low-Middle Income Countries are eligible for a 30% waiver
• Publication fees are periodically reviewed and can be informed to authors by direct communication. Additional fees for colored pictures and extra pages are also applicable. 
• For more details about the article processing charges you can contact:  https://ejmm.journals.ekb.eg/